Press release
Janus Kinase (JAK) Inhibitors Market Trends, Top Companies, Share, Growth And Forecast 2032
Janus Kinase (JAK) Inhibitors Market
The Business Research Company's Janus Kinase (JAK) InhibitorsGlobal Market Report 2023 identifies the increase in instances of autoimmune diseases as the major driver for the janus kinase (JAK) inhibitors market's growth in the forecast period. Autoimmune diseases are a broad group of disorders characterized by an abnormal immune response in which the immune system mistakenly attacks and damages healthy cells, tissues, and organs. Janus Kinase (JAK) inhibitors provide therapeutic benefits for autoimmune diseases by modulating the immune system, reducing inflammation, and alleviating symptoms such as rheumatoid arthritis.
The global Janus Kinase (JAK) inhibitors market is expected to grow from $14.61 billion in 2022 to $17.29 billion in 2023 at a compound annual growth rate (CAGR) of 18.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The Janus Kinase (JAK) inhibitors market is expected to reach $33.38 billion in 2027 at a CAGR of 17.9%.
Download Free Sample Of Janus Kinase (JAK) InhibitorsMarket Report - https://www.thebusinessresearchcompany.com/sample_request?id=12467&type=smp
Major competitors in the janus kinase (JAK) inhibitors market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., GSK Plc., Takeda Pharmaceutical Company Ltd., Eli Lilly and Co., Gilead Sciences Inc., Boehringer Ingelheim Group, Teva Pharmaceutical Industries Ltd.
A key trend in the janus kinase (JAK) inhibitors market includes product innovation. Major companies operating in the Janus kinase (JAK) inhibitors market are focused on innovating technologically advanced solutions to sustain their position in the market. For instance, in May 2022, Eli Lilly and Company, a US-based pharmaceutical company, and Incyte, a Switzerland-based biopharmaceutical company, announced the approval of OLUMIANT (baricitinib) by the U.S. Food and Drug Administration (FDA). It is the first and only JAK inhibitor FDA-approved for treating COVID-19 in some hospitalized individuals who need varying levels of oxygen assistance. OLUMIANT is approved for treating adult hospital patients with extracorporeal membrane oxygenation (ECMO), non-invasive or invasive mechanical breathing, or COVID-19 disease 2019 (COVID-19).
Read More On The Global Janus Kinase (JAK) InhibitorsMarket Report Here:
https://www.thebusinessresearchcompany.com/report/janus-kinase-jak-inhibitors-global-market-report
The janus kinase (JAK) inhibitors market is segmented -
• By Inhibitors Type: Ruxolitinib, Tofacitinib, Oclacitinib, Baricitinib, Peficitinib, Other Inhibitor Types
• By Mode Of Administration: Injectable, Oral, Other Modes Of Administration
• By Distribution Channel: Hospital pharmacies, Retail pharmacies, Online pharmacies
• By Application: Autoimmune Disorders, Oncology, Inflammatory Disorders, Metabolic Disorders
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the janus kinase (JAK) inhibitors market.
The Business Research Company's "Global Janus Kinase (JAK) InhibitorsMarket Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Janus Kinase (JAK) InhibitorsMarket Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12467
The Table Of Content For The Janus Kinase (JAK) InhibitorsMarket Include:
1. Executive Summary
2. Janus Kinase (JAK) InhibitorsMarket Characteristics
3. Janus Kinase (JAK) InhibitorsMarket Trends And Strategies
4. Janus Kinase (JAK) InhibitorsMarket - Macro Economic Scenario
5.1. Global Janus Kinase (JAK) InhibitorsHistoric Market Size and Growth, 2017 - 2022, Value ($ Billion)
……
32. Global Janus Kinase (JAK) InhibitorsMarket Competitive Benchmarking
33. Global Janus Kinase (JAK) InhibitorsMarket Competitive Dashboard
34. Key Mergers And Acquisitions In The Janus Kinase (JAK) InhibitorsMarket
35. Janus Kinase (JAK) InhibitorsMarket Future Outlook and Potential Analysis
36. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Janus Kinase (JAK) Inhibitors Market Trends, Top Companies, Share, Growth And Forecast 2032 here
News-ID: 3258551 • Views: …
More Releases from The Business research company
Emerging Growth Patterns, Segment Analysis, and Competitive Approaches Influenci …
The multi-fiber push on (MPO) or mechanical transfer push-on (MTP) cabling assemblies market is on track for significant expansion in the coming years, driven by advancements in data transmission technology and increasing demand for efficient connectivity solutions. As digital transformation accelerates across industries, these cabling assemblies are becoming essential components in modern network infrastructure. Below is a detailed overview of the market's size, key drivers, leading players, trends, and main…
Analysis of Key Market Segments Driving the Microproteins Skincare Market
The microproteins skincare market is gaining significant traction as consumers increasingly seek effective, science-driven beauty solutions. With innovations in peptide technology and a growing focus on personalized skincare, this market is on a promising growth trajectory. Let's explore the current market size, leading players, influential trends, and segmentation details shaping this dynamic sector.
Projected Growth and Market Size of the Microproteins Skincare Market
The microproteins skincare market is projected to experience robust…
Market Trend Analysis: The Impact of Recent Innovations on the Medical Device Br …
The medical device brazing service market is on track for substantial growth in the coming years, driven by advancing technologies and evolving healthcare needs. As the demand for reliable and efficient medical devices rises, the brazing services that enable precision joining of components are becoming increasingly vital. Let's explore the market size projections, key players, segmentation details, and emerging trends shaping this industry.
Medical Device Brazing Service Market Size and Growth…
Segmentation, Major Trends, and Competitive Overview of the Lifestyle-Related Di …
The lifestyle-related disease supplements market is rapidly evolving as consumers become more health-conscious and proactive about managing chronic conditions linked to lifestyle choices. With an aging global population and increasing disposable incomes, this sector is set for impressive growth. Let's explore the market size, key players, trends, and segmentation that are shaping its future trajectory.
Projected Market Size and Growth Rate for Lifestyle-Related Disease Supplements
The lifestyle-related disease supplements market is on…
More Releases for JAK
Key Trends Influencing the Growth of the Janus Kinase (JAK) Inhibitors Market in …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Janus Kinase (JAK) Inhibitors Market Through 2025?
The market size of Janus Kinase (JAK) inhibitors has experienced a quick growth over the recent years. The market, which stood at $20.19 billion in 2024, is projected to see a rise to $23.56 billion…
Global Jak And Pi3k Signaling Pathway Market Size by Application, Type, and Geog …
According to Market Research Intellect, the global Jak And Pi3k Signaling Pathway market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The JAK and PI3K signaling pathway market is experiencing significant growth due to the increasing…
Leading Growth Driver in the Janus Kinase (JAK) Inhibitors Market in 2025: Surgi …
Which drivers are expected to have the greatest impact on the over the janus kinase (jak) inhibitors market's growth?
The escalating occurrences of autoimmune disorders are anticipated to stimulate the expansion of the Janus kinase (JAK) inhibitors market. These disorders involve a broad spectrum of abnormalities within the immune system where it erroneously attacks and destroys healthy cells, tissues, and organs. The therapeutic benefits of Janus Kinase (JAK) inhibitors for autoimmune…
Janus Kinase (JAK) Inhibitor Pipeline Therapeutics Assessment Report 2024 (Updat …
DelveInsight's, "Janus Kinase Inhibitor Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Janus Kinase (JAK) Inhibitor pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Janus Kinase…
Janus kinase (JAK) Inhibitors Competitive Landscape Report 2024
DelveInsight's, "Janus kinase inhibitors Competitive landscape 2024" report provides comprehensive insights about 40+ Janus kinase Inhibitors Companies and 45+ drugs in Janus kinase inhibitors Competitive landscape. It covers the Janus kinase Inhibitors therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Janus kinase Inhibitors Report
• DelveInsight's Janus kinase Inhibitors report depicts a robust space…
Janus Kinase (JAK) Inhibitors Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Janus Kinase (JAK) Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Janus Kinase (JAK) Inhibitors players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Janus Kinase (JAK)…
